Skip to main content

Direct Molecular Diagnosis of Multiple Endocrine Neoplasia Type 1

  • Protocol
Molecular Pathology Protocols

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 49))

  • 956 Accesses

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant syndrome characterized by the predisposition to develop both peptic ulcer disease and a wide variety of endocrine tumors usually in adolescence and adulthood. Specifically, hyperplasia and/or tumors (most often adenomas) of the parathyroid, pancreatic islet cells, anterior pituitary, and adrenal cortical glands are classically described in affected individuals who have MEN1 (1,2). MEN1 is a highly penetrant disorder whose onset is generally during adult life with the occurrence of at least one, but most often more than one, of the aforementioned tumors. The age-related penetrance of this disorder based on analysis in 63 unrelated kindreds is 7, 52, 87, 98, 99, and 100% by 10, 20, 30, 40, 50, and 60 yr, respectively (3). The disorder is estimated to occur in approx 1 in 30,000 to 1 in 50,000 individuals. Most cases are associated with a positive family history of the disorder, but new germline mutations have been identified in a small percentage of individuals having a negative family history of the disorder but classic features of MEN1 (37).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

oReferences

  1. Miller, J. A. and Norton, J. A. (1997) Multiple endocrine neoplasia. Cancer Treat. Res. 90, 213–225.

    PubMed  CAS  Google Scholar 

  2. Thakker, R. V. (1998) Multiple endocrine neoplasia-syndromes of the twentieth century. J. Clin. Endocrinol. Metab. 83, 2617–2620.

    Article  PubMed  CAS  Google Scholar 

  3. Bassett, J. H., Forbes, S. A., Pannett, A. A., et al. (1998) Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am. J. Hum. Genet. 62, 232–244.

    Article  PubMed  CAS  Google Scholar 

  4. Agarwal, S. K., Kester, M. B., Debelenko, L. V., et al. (1997) Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum. Mol. Genet. 6, 1169–1175.

    Article  PubMed  CAS  Google Scholar 

  5. Giraud, S., Zhang, C. X., Serova-Sinilnikova, O., et al. (1998) Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am. J. Hum. Genet. 63, 455–467.

    Article  PubMed  CAS  Google Scholar 

  6. Sato, M., Matsubara, S., Miyauchi, A., Ohye, H., Imachi, H., Murao, K., and Takahara, J. (1998) Identification of five novel germline mutations of the MEN1 gene in Japanese multiple endocrine neoplasia type 1 (MEN1) families. J. Med. Genet. 35, 915–919.

    Article  PubMed  CAS  Google Scholar 

  7. Teh, B. T., Kytola, S., Farnebo, F., et al. (1998) Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J. Clin. Endocrinol. Metab. 83, 2621–2626.

    Article  PubMed  CAS  Google Scholar 

  8. Yu, F., Venzon, D. J., Serrano, J., Goebel, S. U., Doppman, J. L., Gibril, F., and Jensen, R.T. (1999) Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syn-drome. J. Clin. Oncol. 17, 615–630.

    PubMed  CAS  Google Scholar 

  9. Bystrom, C., Larsson, C., Blomberg, C., Sandelin, K., Falkmer, U., Skogseid, B., Oberg, K., Werner, S., and Nordenskjold, M. (1990) Localization of the MEN1 gene to a small region within chromosome 1 1q13 by deletion mapping in tumors. Proc. Natl. Acad. Sci. USA 87, 1968–1972.

    Article  PubMed  CAS  Google Scholar 

  10. Bale, S. J., Bale, A. E., Stewart, K., Dachowski, L., McBride, O. W., Glaser, T., Green, J. E. III, Mulvihill, J. J., Brandi, M. L., and Sakaguchi, K. (1989) Linkage analysis of multiple endocrine neoplasia type 1 with INT2 and other markers on chromosome 11. Genomics 4, 320–322 (published erratum appears in Genomics1989;5[1], 166).

    Article  PubMed  CAS  Google Scholar 

  11. Courseaux, A., Grosgeorge, J., Gaudray, P., et al. (1996) Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 1 1q13. The European Consortium on Men1 (GENEM 1; Groupe d’Etude des Neoplasies Endocriniennes Multiples de type 1). Genomics 37, 354–365.

    Article  PubMed  CAS  Google Scholar 

  12. Guru, S. C., Agarwal, S. K., Manickam, P., et al. (1997) A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. Genome Res. 7, 725–735.

    PubMed  CAS  Google Scholar 

  13. Larsson, C., Skogseid, B., Oberg, K., Nakamura, Y., and Nordenskjold, M. (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332, 85–87.

    Article  PubMed  CAS  Google Scholar 

  14. Lemmens, I., Merregaert, J., Van de Ven, W. J., et al. (1997) Construction of a 1.2-Mb sequence-ready contig of chromosome 1 1q13 encompassing the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Genomics 44, 94–100.

    Article  PubMed  CAS  Google Scholar 

  15. Nakamura, Y., Larsson, C., Julier, C., Bystrom, C., Skogseid, B., Wells, S., Oberg, K., Carlson, M., Taggart, T., and O’Connell, P. (1989) Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11. Am. J. Hum. Genet. 44, 751–755.

    PubMed  CAS  Google Scholar 

  16. Knudson, A. G. (1971) Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68, 820–823.

    Article  PubMed  Google Scholar 

  17. Chandrasekharappa, S. C., Guru, S. C., Manickam, P., et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276, 404–407.

    Article  PubMed  CAS  Google Scholar 

  18. Guru, S. C., Goldsmith, P. K., Burns, A. L., Marx, S. J., Spiegel, A. M., Collins, F. S., and Chandrasekharappa, S. C. (1998) Menin, the product of the MEN1 gene, is a nuclear protein. Proc. Natl. Acad. Sci. USA 95, 1630–1634.

    Article  PubMed  CAS  Google Scholar 

  19. Agarwal, S. K., Guru, S. C., Heppner, C., et al. (1999) Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96, 143–152.

    Article  PubMed  CAS  Google Scholar 

  20. Bear, J. C., Briones-Urbina, R., Fahey, J. F., and Farid, N. R. (1985) Variant multiple endocrine neoplasia I (MEN IBurin): further studies and non-linkage to HLA. Hum. Hered. 35, 15–20.

    Article  PubMed  CAS  Google Scholar 

  21. Farid, N. R., Buehler, S., Russell, N. A., Maroun, F. B., Allerdice, P., and Smyth, H. S. (1980) Prolactinomas in familial multiple endocrine neoplasia syndrome type I: relationship to HLA and carcinoid tumors. Amer. J. Med. 69, 874–880.

    Article  PubMed  CAS  Google Scholar 

  22. Petty, E. M., Green, J. S., Marx, S. J., Taggart, R. T., Farid, N., and Bale, A. E. (1994) Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 1 1q: evidence for a founder effect in patients from Newfoundland. Am. J. Hum. Genet. 54, 1060–1066.

    PubMed  CAS  Google Scholar 

  23. Olufemi, S. E., Green, J. S., Manickam, P., et al. (1998) Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN 1 (MEN1Burin) in four kindreds from Newfoundland. Hum. Mutat. 11, 264–269.

    Article  PubMed  CAS  Google Scholar 

  24. Krawczak, M. and Cooper, D. N. (1997) The Human Gene Mutation Database. Trends Genet. 13, 121–122.

    Article  PubMed  CAS  Google Scholar 

  25. Lemmens, I., Van de Ven, W. J., Kas, K., et al. (1997) Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum. Mol. Genet. 6, 1177–1183.

    Article  PubMed  CAS  Google Scholar 

  26. Carling, T., Correa, P., Hessman, O., Hedberg, J., Skogseid, B., Lindberg, D., Rastad, J., Westin, G., and Akerstrom, G. (1998) Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 83, 2960–2963.

    Article  PubMed  CAS  Google Scholar 

  27. Debelenko, L. V., Brambilla, E., Agarwal, S. K., et al. (1997) Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum. Mol. Genet. 6, 2285–2290.

    Article  PubMed  CAS  Google Scholar 

  28. Farnebo, F., Teh, B. T., Kytola, S., Svensson, A., Phelan, C., Sandelin, K., Thompson, N. W., Hoog, A., Weber, G., Farnebo, L.O., and Larsson, C. (1998) Alterations of the MEN1 gene in sporadic parathyroid tumors. J. Clin. Endocrinol. Metab. 83, 2627–2630.

    Article  PubMed  CAS  Google Scholar 

  29. Görtz, B., Roth, J., Speel, E. J. M., Krähenmann, A., DeKrijger, R. R., Matias-Guiu, X., Muletta-Feurer, S., Rütmann, K., Saremaslani, P., Heitz, P. U., and Komminoth, P. (1999) MEN1 gene mutation analysis of sporadic adrenocortical lesions. Int. J. Cancer 80, 373–379.

    Article  PubMed  Google Scholar 

  30. Shou, W., Seol, J. H., Shevchenko, A., Baskerville, C., Moazed, D., Chen, Z. W. S., Jang, J., Shevchenko, A., Charbonneau, H., and Deshaies, R. J. (1999) Exit from mitosis is triggered by Tem1-dependent release of the protein phosphatase Cdc14 from nucleolar RENT complex. Cell 97, 233–244.

    Article  PubMed  CAS  Google Scholar 

  31. Prezant, T. R., Levine, J., and Melmed, S. (1998) Molecular characterization of the men1 tumor suppressor gene in sporadic pituitary tumors. J. Clin. Endocrinol. Metab. 83, 1388–1391.

    Article  PubMed  CAS  Google Scholar 

  32. Sawicki, M. P., Wan, Y. J., Johnson, C. L., Berenson, J., Gatti, R., and Passaro, E. Jr. (1992) Loss of heterozygosity on chromosome 11 in sporadic gastrinomas. Hum. Genet. 89, 445–449.

    Article  PubMed  CAS  Google Scholar 

  33. Vortmeyer, A. O., Boni, R., Pak, E., Pack, S., and Zhuang, Z. (1998) Multiple endocrine neoplasia 1 gene alterations in MEN1-associated and sporadic lipomas. J. Natl. Cancer Inst. 90, 398–399.

    Article  PubMed  CAS  Google Scholar 

  34. Teh, B. T., Esapa, C. T., Houlston, R., Grandell, U., Farnebo, F., Nordenskjold, M., Pearce, C. J., Carmichael, D., Larsson, C., and Harris, P. E. (1998) A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors. Am. J. Hum. Genet. 63, 1544–1549.

    Article  PubMed  CAS  Google Scholar 

  35. Zhuang, Z., Ezzat, S. Z., Vortmeyer, A. O., et al. (1997) Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res. 57, 5446–5451.

    PubMed  CAS  Google Scholar 

  36. Korf, B. R. and Pagon, R. A. (1998) Overview of molecular genetic diagnosis (Unit 9.1), in Current Protocols in Human Genetics (Dracopoli, N. C., Haines, J. L., Korf, B. R., et al., eds.), John Wiley & Sons, New York, pp. 9.1.1–9.1.9.

    Google Scholar 

  37. Smooker, P. M. and Cotton, R. G. (1993) The use of chemical reagents in the detection of DNA mutations. Mutat. Res. 288, 65–77.

    PubMed  CAS  Google Scholar 

  38. Bottema, C. D. and Sommer, S. S. (1993) PCR amplification of specific alleles: rapid detection of known mutations and polymorphisms. Mutat. Res. 288, 93–102.

    PubMed  CAS  Google Scholar 

  39. Hayashi, K. (1991) PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl. 1, 34–38.

    PubMed  CAS  Google Scholar 

  40. Loda, M. (1994) Polymerase chain reaction-based methods for the detection of mutations in oncogenes and tumor suppressor genes. Human Pathol. 25, 564–571.

    Article  CAS  Google Scholar 

  41. Sidransky, D. (1997) Nucleic acid-based methods for the detection of cancer. Science 278, 1054–1058.

    Article  PubMed  CAS  Google Scholar 

  42. Liu, Q., Feng, J., and Sommer, S. S. (1996) Bi-directional dideoxy fingerprinting (Bi-ddF): a rapid method for quantitative detection of mutations in genomic regions of 300-600 bp. Hum. Mol. Genet. 5, 107–114.

    Article  PubMed  CAS  Google Scholar 

  43. Ben-Ezra, J. (1995) Amplification methods in the molecular diagnosis of genetic diseases. Clin. Lab. Med. 15, 795–815.

    PubMed  CAS  Google Scholar 

  44. McPherson, R. (1995) Molecular basis of genetic disease and molecular methods. Clin. Lab. Med. 15, 779–794.

    PubMed  CAS  Google Scholar 

  45. Wagener, C., Epplen, J. T., Erlich, H., Peretz, H., and Vihko, P. (1994) Molecular biology techniques in the diagnosis of monogenic diseases. Clin. Chim. Acta 225, S35–S50.

    Article  PubMed  CAS  Google Scholar 

  46. Grompe, M. (1993) The rapid detection of unknown mutations in nucleic acids. Nat. Genet. 5, 111–117.

    Article  PubMed  CAS  Google Scholar 

  47. Blaszyk, H., Hartmann, A., Schroeder, J. J., McGovern, R. M., Sommer, S. S., and Kovach, J. S. (1995) Rapid and efficient screening for p53 gene mutations by dideoxy fingerprinting (ddF). BioTech 18, 256–260.

    CAS  Google Scholar 

  48. Warren, W., Hovig, E., Smith-Sorensen, B., Borresen, A. L., Fujimura, F. K., Liu, Q., Feng, J., and Sommer, S. S. (1997) Detection of mutations by single-strand conformation polymorphism (SSCP) analysis and SSCP-hybrid methods (Unit 7.4), in Current Protocols in Human Genetics (Dracopoli, N. C., Haines, J. L., Korf, B. R., et al., eds.), John Wiley & Sons, New York, pp. 7.4.1–7.4.23.

    Google Scholar 

  49. Mashal, R. D., Koontz, J., and Sklar, J. (1995) Detection of mutations by cleavage of DNA heteroduplexes with bacteriophage resolvases. Nat. Genet. 9, 177–183.

    Article  PubMed  CAS  Google Scholar 

  50. Sekiya, T. (1993) Detection of mutant sequences by single-strand conformation polymorphism analysis. Mutat. Res. 288, 79–83.

    PubMed  CAS  Google Scholar 

  51. Dracopoli, N., ed. (1994) Current Protocols in Human Genetics, John Wiley & Sons, New York.

    Google Scholar 

  52. Cotton, R.G. (1993) Current methods of mutation detection. Mutat. Res. 285, 125–144.

    PubMed  CAS  Google Scholar 

  53. Thierfelder, L. (1998) Mutation detection by cycle sequencing (Unit 7.7), in Current Protocols in Human Genetics (Dracopoli, N. C., Haines, J. L., Korf, B. R., et al., eds.), John Wiley & Sons, New York, pp. 7.7.1–7.7.6.

    Google Scholar 

  54. Shuldiner, A. R., LeRoith, D., and Roberts, C. T. (1995) DNA sequence analysis, in Molecular Endocrinology: Basic Concepts and Clinical Correlations (Weintraub, B. D., ed.), Raven Press, New York, pp. 13–21.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Humana Press Inc.

About this protocol

Cite this protocol

Petty, E.M., Glynn, M., Bale, A.E. (2001). Direct Molecular Diagnosis of Multiple Endocrine Neoplasia Type 1. In: Killeen, A.A. (eds) Molecular Pathology Protocols. Methods in Molecular Medicine™, vol 49. Humana Press. https://doi.org/10.1385/1-59259-081-0:227

Download citation

  • DOI: https://doi.org/10.1385/1-59259-081-0:227

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-681-9

  • Online ISBN: 978-1-59259-081-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics